12 Pulmonary Hypertension Clinical Trials in New Orleans, LA (2026)

Q: How do I join a clinical trial in New Orleans?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you.

Recruiting Pulmonary Hypertension Studies in New Orleans

NCT05254743Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment...

New Orleans, LAPHASE3737 participantsLoxo Oncology, Inc.

View Study Details

NCT07288398Recruiting

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with p...

New Orleans, LAPHASE3540 participantsTenax Therapeutics, Inc.

View Study Details

NCT03269630Recruiting

New Orleans Pulmonary Hypertension Biobank

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub...

New Orleans, LA450 participantsLouisiana State University Health Sciences Center in New Orleans

View Study Details

NCT05813678Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

This is a 10-year multi-center, global, observational study to further characterize the safety profile of pegvaliase, including hypersensitivity reactions, long-term safety and tolerability, and the e...

New Orleans, LA450 participantsBioMarin Pharmaceutical

View Study Details

NCT04228978Recruiting

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk dis...

New Orleans, LANA212 participantsNorthwestern University

View Study Details

NCT04757116Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift....

New Orleans, LANA206 participantsOlympus Corporation of the Americas

View Study Details

NCT06305234Recruiting

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

This is a 10-year multi-center, prospective, longitudinal, single arm study evaluating immunologic, inflammatory and laboratory parameters associated with long-term Palynziq treatment in subjects with...

New Orleans, LA200 participantsBioMarin Pharmaceutical

View Study Details

NCT05663684Recruiting

Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?

Purpose: It is unknown whether instillation of a drop of anesthetic ophthalmic solution into the eye such as proparacaine hydrochloride 0.5% prior to probing and irrigation of the tear duct (lacrimal ...

New Orleans, LAPHASE4145 participantsLouisiana State University Health Sciences Center in New Orleans

View Study Details

NCT06379789Recruiting

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an ex...

New Orleans, LAPHASE1130 participantsRegeneron Pharmaceuticals

View Study Details

NCT04920617Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refr...

New Orleans, LAPHASE2102 participantsImmunoVaccine Technologies, Inc. (IMV Inc.)

View Study Details

NCT06412666Recruiting

A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

The purpose of this study is to evaluate the efficacy, safety and PK of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)....

New Orleans, LAPHASE255 participantsCytokinetics

View Study Details

NCT04626791Recruiting

Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

This phase II trial investigates how well modified VR-CAP (bortezomib, rituximab, cyclophosphamide, doxorubicin hydrochloride, prednisone, and cytarabine hydrochloride) and acalabrutinib as first line...

New Orleans, LAPHASE245 participantsAcademic and Community Cancer Research United

View Study Details

About Pulmonary Hypertension Clinical Trials in New Orleans

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 12 pulmonary hypertension clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 3,272 participants. Research is being sponsored by Loxo Oncology, Inc., Tenax Therapeutics, Inc., Louisiana State University Health Sciences Center in New Orleans and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in New Orleans — FAQ

Are there pulmonary hypertension clinical trials in New Orleans?

Yes, there are 12 pulmonary hypertension clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 12 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 19, 2026 from ClinicalTrials.gov